VERSARTIS INC's ticker is VSAR and the CUSIP is 92529L102. A total of 101 filers reported holding VERSARTIS INC in Q2 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $276,000 | -31.2% | 197,149 | -0.6% | 0.00% | – |
| Q2 2018 | $401,000 | -7.6% | 198,288 | -24.7% | 0.00% | – |
| Q1 2018 | $434,000 | -24.4% | 263,354 | +0.9% | 0.00% | – |
| Q4 2017 | $574,000 | -13.2% | 260,944 | -3.3% | 0.00% | – |
| Q3 2017 | $661,000 | -85.5% | 269,980 | +3.2% | 0.00% | -100.0% |
| Q2 2017 | $4,563,000 | -17.0% | 261,506 | +1.6% | 0.00% | 0.0% |
| Q1 2017 | $5,495,000 | +102.0% | 257,417 | +41.0% | 0.00% | +100.0% |
| Q4 2016 | $2,720,000 | +48.6% | 182,552 | +22.2% | 0.00% | 0.0% |
| Q3 2016 | $1,830,000 | +12.9% | 149,421 | +1.9% | 0.00% | 0.0% |
| Q2 2016 | $1,621,000 | +44.0% | 146,587 | +4.3% | 0.00% | 0.0% |
| Q1 2016 | $1,126,000 | -30.3% | 140,495 | +7.7% | 0.00% | 0.0% |
| Q4 2015 | $1,616,000 | +7.9% | 130,508 | +0.5% | 0.00% | 0.0% |
| Q3 2015 | $1,497,000 | -8.7% | 129,870 | +20.5% | 0.00% | 0.0% |
| Q2 2015 | $1,640,000 | -8.1% | 107,811 | +10.9% | 0.00% | 0.0% |
| Q1 2015 | $1,785,000 | +32.9% | 97,198 | +62.4% | 0.00% | 0.0% |
| Q4 2014 | $1,343,000 | +21.3% | 59,866 | +2.6% | 0.00% | 0.0% |
| Q3 2014 | $1,107,000 | -31.4% | 58,325 | +1.4% | 0.00% | 0.0% |
| Q2 2014 | $1,613,000 | – | 57,531 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,296,471 | $51,556,000 | 25.09% |
| Aisling Capital LLC | 1,994,568 | $44,778,000 | 6.79% |
| Opaleye Management Inc. | 235,000 | $5,276,000 | 2.67% |
| Perceptive Advisors | 931,171 | $19,740,000 | 1.66% |
| HealthCor Management, L.P. | 875,000 | $19,644,000 | 1.10% |
| Cormorant Asset Management, LP | 200,000 | $4,490,000 | 0.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 644,150 | $14,461,000 | 0.63% |
| RA Capital Management | 231,267 | $5,192,000 | 0.56% |
| Baker Brothers Advisors | 2,281,744 | $51,225,000 | 0.52% |
| PFM Health Sciences, LP | 869,463 | $19,519,000 | 0.46% |